The Effect of Mandala on Nausea, Vomiting, Pain and Anxiety in Chemotherapy Patients

January 21, 2025 updated by: Fahri AŞKAN, Cukurova University

The Effect of Mandala Art Therapy (Coloring) on Nausea, Vomiting, Pain and Anxiety in Children Receiving Outpatient Chemotherapy

To determine the effect of mandala art therapy (coloring) on nausea, vomiting, pain and anxiety in children receiving outpatient chemotherapy. The concept of cancer is used to describe a group of diseases that start from a single cell and show uncontrolled growth, proliferation and spread to surrounding tissues. The cooperation of the family and the healthcare team plays a major role in the success of the treatment. Surgical treatment, radiotherapy and chemotherapy are applied in its treatment. Art therapy, a method of distraction, is used to prevent pediatric oncology patients from focusing on the pain and stressful life events they experience. By having children do artistic activities in the hospital room, nurses can reduce symptom management, social isolation, and long-term negative social effects.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cancer treatment in children is determined according to the type of cancer, its stage and the child's general health condition. Treatment options include the following; chemotherapy, radiotherapy, surgery, immunotherapy and targeted therapy. The following problems are observed in children receiving chemotherapy in the short and long term: fever, fatigue, weight loss, pain, fatigue, anxiety, nausea and vomiting, changes in sleep and mood. 91% of oncology patients have benefited from Complementary and Alternative Medicine (CAM), such as art, to improve their general health, and painting, painting, music and dance, and mind-body therapies have been shown to have positive effects on the quality of life in pediatric oncology patients.

Art therapy in the pediatric oncology patient population. The American Art Therapy Association (AATA) (2013) defines art therapy as healing. Increasing the physical, mental and emotional well-being of individuals is considered as creative interventions of art production. These interventions have been widely used as alternative treatments for a variety of conditions, including cancer.

Although there is a significant amount of research on the effects of art therapies, there is a lack of research in the existing literature regarding their specific effects on symptoms such as nausea, vomiting, pain, and anxiety. However, the effects on quality of life are generally given more attention.

Among the art therapies; Mandala art therapy is a type of art therapy using circular patterns and symbols. In this therapy, participants explore their inner world and express their emotions by creating their own mandates. It gives individuals the opportunity to concretize the complex and abstract thoughts in their minds caused by their painful experiences. Emotions and thoughts are spontaneously embedded in artistic products such as sculpture, music, painting, marbling and mandala. Mandala therapy improves creativity and problem-solving skills by increasing emotional awareness and expression.

As a result, mandala art therapy can be used in the treatment of many different problems such as stress, anxiety, depression, trauma and chronic disease, as well as in the management of symptoms.

To determine the sample size of the study, the power of the study was calculated with the G-Power 3.1.9.2 program using the confidence interval and effect size parameters. 80% power, 95% confidence interval and effect size of 0.5 or more. In the G-Power 3.1.9.2 program, the total sample size was calculated as 48 (24+24) based on 0.05 significance, 0.80 large effect and 80% power. However, considering the 10% loss and taking into account the parametric test assumption, the sample number of each group was determined as 30 people in the intervention group and 30 people in the control group, for a total of 60 people.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Balçalı
      • Adana, Balçalı, Turkey, 01250
        • Çukurova University Balcalı Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being at the pediatric chemotherapy clinic to receive outpatient chemotherapy
  • Receiving daily chemotherapy
  • Those who agreed to participate in the research
  • Mother and child must know Turkish
  • The child knows colors

Exclusion Criteria:

  • Having a mental health problem (preventing the use of Mandala therapy coloring technique)
  • Having a disability that prevents you from seeing or using your hand (a condition that prevents you from using the Mandala therapy coloring technique)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
In this study, the control group will receive standard care.
Experimental: Experimantal group
Individual mandala activity will be carried out in all sample groups after admission to the clinic where they come to receive outpatient chemotherapy and when they start taking medication.
Individual mandala activity will be carried out in all sample groups after admission to the clinic where they come to receive outpatient chemotherapy and when they start taking medication. Children will color (paint).
Other Names:
  • Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Rating scale
Time Frame: Approximately 2 hours from start
It is a visual analog scale used to evaluate the intensity of pain. This scale includes six different facial expressions scored from 0 to 10. 0 means "no pain," while 10 means "most severe pain." The scale is used to diagnose pain in children aged 3-18. Pain scores are given according to the numerical values given to the faces on the scale. The lowest score is "1" and the highest score is "5". As the score from the scale increases, pain tolerance decreases, and as the score decreases, tolerance increases.
Approximately 2 hours from start

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nausea and Vomiting Thermometer in Children with Cancer
Time Frame: Approximately 2 hours from start
The Nausea and Vomiting Thermometer Scale in Children with Cancer is a tool used to evaluate the frequency and severity of nausea and vomiting in children with cancer aged 0-18 years. The structure of the scale consists of 2 subscales: Nausea: 0 (no nausea) - 10 (most severe nausea), Vomiting: 0 (no vomiting) - 10 (most severe vomiting), Visuals using 5 different colors and emojis for each subscale. A thermometer was created.
Approximately 2 hours from start

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2024

Primary Completion (Actual)

October 15, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

July 8, 2024

First Submitted That Met QC Criteria

July 12, 2024

First Posted (Actual)

July 18, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 21, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Mandala group

Subscribe